Not surprising. The New CFO cannot answer basic questions about the huge cash burn for the quarter. No guidance on giving guidance. Poor timing of news events. They are running on cash fumes yet they wait till the last minute to do a deal since AbbVie did not come in. The CFO should have been more prudent and NOT counted on any monies from AbbVie coming in. You count on it when its in your coffers, not the hopes of having it. A deal could have been done not long ago at a much higher price. Poor execution all around, no wonder we are where we are.
The company has great products and I invested in UNIS because of that.......but there is much more to a company than its products.
UNS Price at posting:
44.0¢ Sentiment: Hold Disclosure: Held
